CSTL logo

CSTLCastle Biosciences Inc

$21.01
$0.59
(2.73%)
Today
Closed $21.01
$0.00
(0.00%)
After Hours
Updated: 04:15 PM EDT
EarningsAug 3
Mkt Cap$655.13M
Vol212,465.00

About

Castle Biosciences, Inc.is a molecular diagnostics company offering innovative test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, barrett’s esophagus, uveal melanoma, and in the treatment of mental health conditions. The firm offers DecisionDx-Melanoma, a proprietary multi-gene expression profile (GEP) test that predicts the risk of metastasis and recurrence for patients diagnosed with invasive cutaneous melanoma. It also markets DecisionDx-UM, Decision Dx DiffDx-Melanoma, DecisonDx-CMSeq, DecisionDx-SCC, DecsionDx-UMSeq, and DecisonDX-PRAME. The company was founded by Derek J. Maetzold in September 2007 and is headquartered in Friendswood, TX.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
883

Frequently Asked Questions

What is Market Cap of Castle Biosciences Inc?
What is the 52-week high for Castle Biosciences Inc?
What is the 52-week low for Castle Biosciences Inc?
What is Castle Biosciences Inc stock price today?
What was Castle Biosciences Inc stock price yesterday?
What is the PE ratio of Castle Biosciences Inc?
What is the Price-to-Book ratio of Castle Biosciences Inc?
What is the 50-day moving average of Castle Biosciences Inc?
How many employees does Castle Biosciences Inc have?

Advertisement|Remove ads.